by Madaline Spencer | Jul 13, 2026
The US Food and Drug Administration (FDA) has granted accelerated approval to Trutakna (atacicept) for the treatment of adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression. IgAN is due to the accumulation of IgA antibodies in the...
by Madaline Spencer | Jul 10, 2026
Kristen Rohli, PhD, Associate Director of Research at Congenital Hyperinsulinism International, discusses congenital hyperinsulinism (HI) diagnosis and management. Congenital HI is a condition caused by abnormally high levels of insulin, a hormone that...
by Madaline Spencer | Jul 9, 2026
Rachel Gafni, MD, Senior Research Physician at the National Institutes of Health, discusses results from the CALIBRATE clinical trial in patients with autosomal dominant hypocalcemia type 1 (ADH1). ADH1 is a rare form of hypoparathyroidism caused by...
by Madaline Spencer | Jul 8, 2026
Melanie Gander, mother of a son with congenital adrenal hyperplasia (CAH), and Ambassador with Neurocrine Biosciences, discusses her son’s diagnostic journey with congenital adrenal hyperplasia (CAH). CAH refers to a group of genetic conditions that...
by Madaline Spencer | Jul 7, 2026
Kate Stratton, Executive Director of Lipodystrophy United, discusses mental health challenges and care gaps in patients with lipodystrophy. Lipodystrophies are rare metabolic disorders characterized by the loss of adipose tissue. This leads to...
